Stockscreener 앱 받기
45.81
0.88%
0.4008
전일 마감가:
$45.41
열려 있는:
$45.54
하루 거래량:
2,535
Relative Volume:
0.25
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.69%
1개월 성능:
-4.17%
6개월 성능:
+24.50%
1년 성능:
+18.25%
1일 변동 폭
$45.54
$46.64
1주일 범위
$45.03
$46.90
52주 변동 폭
$27.20
$51.42
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
45.81 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.65 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.75 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.76 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
276.30 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
601.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf 주식(GNOM)의 최신 뉴스
(GNOM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
7 Best Biotech ETFs to Buy Now - US News Money
5 Small-cap Biotech ETFs to Watch - Nasdaq
Entravision Communications (NYSE:EVC) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Lakeland Financial (NASDAQ:LKFN) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
German American Bancorp (NASDAQ:GABC) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
AlTi Global (NASDAQ:ALTI) Shares Pass Above Two Hundred Day Moving Average – What’s Next? - Defense World
Demand Brands (OTCMKTS:DMAN) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Mercury General (NYSE:MCY) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Riverview Bancorp (NASDAQ:RVSB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Infrastructure Stocks To Follow Today – February 8th - Defense World
IBBQ, GNOM, BIB: Gain Exposure to Healthcare Startups with Biotech ETFs - TipRanks
Chimerix Shares Approach Peak on Partner’s Rosy Forecast - AD HOC NEWS
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
Best Biotech ETFs to Buy in 2026 - The Motley Fool
How (GNOM) Movements Inform Risk Allocation Models - Stock Traders Daily
Trading Systems Reacting to (GNOM) Volatility - Stock Traders Daily
Moderna (MRNA) Stock Surge Boosts ETFs with High Exposure - GuruFocus
Moderna’s rally ripples through biotech and health care ETFs - Seeking Alpha
The Next Big Theme: January 2026 - Global X ETFs
Short Interest in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Expands By 23.3% - Defense World
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
FengHe Fund Management Pte. Ltd. Invests $36.48 Million in Ciena Corporation $CIEN - Defense World
Invesco BulletShares 2025 Corporate Bond ETF $BSCP Shares Bought by Farnam Financial LLC - Defense World
Schwab US Large-Cap ETF $SCHX is Farnam Financial LLC’s Largest Position - Defense World
FengHe Fund Management Pte. Ltd. Invests $49.61 Million in Analog Devices, Inc. $ADI - Defense World
Clarity Wealth Advisors LLC Has $9.09 Million Stock Position in JPMorgan Core Plus Bond ETF $JCPB - Defense World
Vanguard Small-Cap ETF $VB Shares Acquired by Farnam Financial LLC - Defense World
Vanguard FTSE Developed Markets ETF $VEA Shares Bought by Farnam Financial LLC - Defense World
Here's Why Biotech ETFs Are Rallying Hard - Nasdaq
How to Buy CRISPR Therapeutics Stock (CRSP) - The Motley Fool
Allspring Global Investments Holdings LLC Sells 1,180,416 Shares of Alight, Inc. $ALIT - Defense World
(GNOM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Archford Capital Strategies LLC Sells 21,216 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Armbruster Capital Management Inc. Has $54.56 Million Holdings in Vanguard U.S. Value Factor $VFVA - Defense World
3 ASX ETFs to target in the new year – the booming themes of 2025 - The Motley Fool Australia
Global X FundsGlobal X Genomics & Biotechnology ETF announces Semi-Annual dividend, payable on January 07, 2026 - marketscreener.com
Acacia Research (NASDAQ:ACTG) Shares Pass Above 200 Day Moving Average – What’s Next? - Defense World
(GNOM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
The Next Big Theme: December 2025 - Seeking Alpha
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Pass Above 200-Day Moving Average – Time to Sell? - Defense World
Touchstone Climate Transition ETF (OTCMKTS:HEAT) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
Liquidity Mapping Around (GNOM) Price Events - Stock Traders Daily
Flow Traders U.S. LLC Buys 82,063 Shares of Global X Genomics & Biotechnology ETF $GNOM - Defense World
Flow Traders U.S. LLC Has $1.71 Million Position in Avantis Short-Term Fixed Income ETF $AVSF - Defense World
Mateon Therapeutics (OTCMKTS:MATN) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World
Biglari (NYSE:BH) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
Global X Genomics Biotechnology Etf (GNOM) 재무 분석
Global X Genomics Biotechnology Etf (GNOM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.74%
0.47%
자본화:
|
볼륨(24시간):